Martin Capital Management’s AbbVie ABBV Stock Holding History

Martin Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1.7M	Sell	25,323 -1,190	-4%	-$77.7K	4.65%	11
2015 Q1	$1.55M	Hold	26,513	–	–	4.39%	10
2014 Q4	$1.74M	Sell	26,513 -2,535	-9%	-$160K	4.48%	10
2014 Q3	$1.68M	Sell	29,048 -1,745	-6%	-$96.9K	5.5%	8
2014 Q2	$1.74M	Sell	30,793 -615	-2%	-$32.3K	5.23%	10
2014 Q1	$1.61M	Sell	31,408 -1,870	-6%	-$94.5K	4.59%	10
2013 Q4	$1.76M	Sell	33,278 -5,762	-15%	-$283K	4.69%	9
2013 Q3	$1.75M	Sell	39,040 -40,882	-51%	-$1.81M	4.19%	10
2013 Q2	$3.3M	Buy	+79,922	New	+$3.5M	7.37%	7

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Martin Capital Management's ABBV Position: Q2 2015 in Review

Martin Capital Management reduced its AbbVie (ABBV) stake by 4.5% in Q2 2015, selling an estimated $77.7K and leaving 25,323 shares worth $1.7M. The position accounts for 4.65% of the portfolio, ranked #11.

Martin Capital Management first reported a position in ABBV in Q2 2013 and has held it in 9 quarters since. The position peaked at $3.3M in Q2 2013. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

Martin Capital Management held 25,323 shares of AbbVie worth $1.7M as of Q2 2015.
Martin Capital Management sold 1,190 AbbVie shares in Q2 2015, an estimated $77.7K.
AbbVie made up 4.65% of Martin Capital Management's portfolio in Q2 2015, its #11 holding.
Martin Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 9 quarters since.
Martin Capital Management's AbbVie position peaked at $3.3M in Q2 2013.
1,653 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Martin Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.